Checked Nov 19, 2026Start a new check

What was checked

They've been rejecting the lung cancer vaccine from Cuba for a decade (implying it's widely curing lung cancer elsewhere but US blocks it)

Assessment summary

Inaccurate

Published evidence does not support claims that CIMAvax has broadly cured thousands of people. It is intended to control tumor growth and has produced limited survival extensions in trials. U.S. access was delayed by the Cuba embargo and required regulatory approval, but the FDA authorized U.S. clinical trials in 2016.

Key findings

Model assessments

Assessment summary

  • The claim is partly accurate because U.S.
  • restrictions and regulatory requirements limited access to Cuba’s CIMAvax, and U.S.
  • trials began only in 2016.politifact.com snopes.com However, CIMAvax is a therapeutic immunotherapy for certain advanced lung cancers, not a widely curative vaccine, and studies showed only modest survival benefits rather than broad cures.politifact.com snopes.com

Claims reviewed

The vaccine is widely curing lung cancer elsewhere.

Contradicted
Published evidence does not support claims that CIMAvax has broadly cured thousands of people. It is intended to control tumor growth and has produced limited survival extensions in trials.politifact.com snopes.com

This claim may mislead readers without added context.

The United States has been rejecting Cuba’s lung cancer vaccine for a decade.

Needs context
U.S. access was delayed by the Cuba embargo and required regulatory approval, but the FDA authorized U.S. clinical trials in 2016.politifact.com snopes.com Calling this simply “rejecting” the vaccine ignores that U.S. researchers later conducted trials.

This claim may mislead readers without added context.

The United States blocks the vaccine.

Needs context
The embargo restricted importing Cuban medicines and initially impeded access, but U.S. authorities approved clinical research and the drug entered U.S. trials.politifact.com snopes.com The evidence does not show a blanket ban intended to prevent an established cure.

This claim may mislead readers without added context.

Assessment summary

  • The claim contains multiple significant factual errors.
  • The US did not reject the vaccine for a decade—clinical trials were approved in 2016.
  • The vaccine does not "widely cure" lung cancer; it extends survival by a few months for some patients with advanced disease.
  • The US did not "block" it; regulatory approval requires evidence-based clinical trials, which are ongoing.

Claims reviewed

They've been rejecting the lung cancer vaccine from Cuba for a decade

Contradicted
The FDA approved clinical trials of CIMAvax in October 2016 medscape.com, not after a decade of rejection. Roswell Park initiated trials in 2017 roswellpark.org. The delay was due to the embargo and regulatory requirements, not outright rejection.

This claim may mislead readers without added context.

It's widely curing lung cancer elsewhere

Contradicted
CIMAvax is not a cure and does not 'widely cure' lung cancer. It is a therapeutic immunotherapy that extends median survival by a few months in advanced cases cubanews.today. It is approved in only 7-8 countries (Cuba, Colombia, Paraguay, Peru, Bosnia, Argentina, Kazakhstan, Belarus) frontiersin.org, not widely.

This claim may mislead readers without added context.

US blocks it

Needs context
The US did not simply 'block' the vaccine. The FDA requires clinical trials to prove effectiveness before approval pbs.org. Trials were approved and conducted at Roswell Park roswellpark.org. The embargo created barriers, but regulatory requirements for evidence-based medicine are standard practice, not a 'block.'

This claim may mislead readers without added context.

Assessment summary

  • The statement mixes a partly-true policy history with a false, broad medical claim.
  • The U.S.
  • did restrict routine access to Cuban medicines for many years, but U.S.
  • institutions obtained FDA permission to begin clinical trials of the Cuban CIMAvax vaccine starting around 2015–2016.

Claims reviewed

(Implied) the Cuban lung cancer vaccine is widely curing lung cancer elsewhere.

Contradicted
Published Cuban studies and international reports show limited trial data and some survival signals, but they do not demonstrate that CIMAvax is "widely curing" lung cancer; evidence is preliminary, not proof of widespread cures pmc.ncbi.nlm.nih.gov aacr.org.

This claim may mislead readers without added context.

They've been rejecting the lung cancer vaccine from Cuba for a decade.

Needs context
The U.S. embargo and regulatory barriers limited routine access, but a formal U.S. clinical-trial pathway was opened and Roswell Park received FDA authorization to study CIMAvax around 2015–2016, so it is incorrect to say the U.S. simply rejected it for a decade without nuance roswellpark.org politifact.com.

This claim may mislead readers without added context.

Sources cited

18 sources

Share this result